Developer of vascular access technology intended to prevent leakage after calculation. The company's technology uses a patch in cannulation-related complications for patients undergoing hemodialysis, enabling doctors to perform surgery with ease and improve patients' lives.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 18-Mar-2019 | 00.000 | Completed | Generating Revenue | ||
5. Grant | 01-Jan-2017 | 00.000 | 00.000 | Completed | Generating Revenue | |
4. Grant | 19-Jan-2016 | 00000 | 00.000 | Completed | Generating Revenue | |
3. Early Stage VC (Series A) | 25-Feb-2014 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
2. Grant | 09-Aug-2013 | $500K | Completed | Generating Revenue | ||
1. Grant | 17-Nov-2011 | $150K | Completed | Generating Revenue |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
James Hong | Chief Executive Officer & Board Member |
Name | Representing | Role | Since |
---|---|---|---|
James Hong | Solinas Medical | Chief Executive Officer & Board Member | 000 0000 |